Show simple item record

The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

dc.contributor.authorDedieu, S
dc.contributor.authorCanron, X
dc.contributor.authorRezvani, H R
dc.contributor.authorBouchecareilh, M
dc.contributor.authorMazurier, F
dc.contributor.authorSinisi, R
dc.contributor.authorZanda, M
dc.contributor.authorMoenner, M
dc.contributor.authorBikfalvi, A
dc.contributor.authorNorth, S
dc.date.accessioned2014-11-21T10:57:01Z
dc.date.available2014-11-21T10:57:01Z
dc.date.issued2010-03-24
dc.identifier995483
dc.identifier95c9778b-62b5-42ad-9580-d05e225e33dc
dc.identifier20334641
dc.identifier77952283596
dc.identifier.citationDedieu , S , Canron , X , Rezvani , H R , Bouchecareilh , M , Mazurier , F , Sinisi , R , Zanda , M , Moenner , M , Bikfalvi , A & North , S 2010 , ' The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A ' , BMC medicine , vol. 8 , 19 . https://doi.org/10.1186/1741-7015-8-19en
dc.identifier.issn1741-7015
dc.identifier.urihttp://hdl.handle.net/2164/3963
dc.format.extent14
dc.format.extent1769775
dc.language.isoeng
dc.relation.ispartofBMC medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleThe cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-Aen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1186/1741-7015-8-19


Files in this item

Thumbnail
Name:
The_cytoprotective.pdf
Size:
1.687Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record